| 24.9 -0.51 (-2.01%) | 12-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 30.35  |
1-year : | 31.81 |
| Resists | First : | 25.98 |
Second : | 27.23 |
| Pivot price | 25 |
|||
| Supports | First : | 23.95 |
Second : | 19.93 |
| MAs | MA(5) : | 25.26 |
MA(20) : | 25.18 |
| MA(100) : | 25.74 |
MA(250) : | 0 | |
| MACD | MACD : | -0.2 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 50.1 |
D(3) : | 54.4 |
| RSI | RSI(14): 44.6 |
|||
| 52-week | High : | 29.62 | Low : | 19.1 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ BLFS ] has closed above bottom band by 42.0%. Bollinger Bands are 61.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 25.42 - 25.62 | 25.62 - 25.76 |
| Low: | 24.43 - 24.66 | 24.66 - 24.81 |
| Close: | 24.6 - 24.95 | 24.95 - 25.19 |
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
Fri, 19 Dec 2025
Is BioLife Solutions, Inc. (NASDAQ:BLFS) Trading At A 49% Discount? - Yahoo Finance
Wed, 17 Dec 2025
Insider Sell: Amy Duross Sells 2,000 Shares of BioLife Solutions Inc (BLFS) - GuruFocus
Fri, 05 Dec 2025
BioLife Solutions (BLFS) CFO Wichterman sells $771,600 in stock - Investing.com
Mon, 01 Dec 2025
BioLife Solutions (NASDAQ:BLFS) Enhances Global Cell Therapy Solutions - Kalkine Media
Mon, 17 Nov 2025
BioLife Solutions (NASDAQ: BLFS) outlines 2025 investor conference schedule and IR deck - Stock Titan
Mon, 17 Nov 2025
BioLife Solutions to Participate in Upcoming Investor Conferences in November and December 2025 - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 48 (M) |
| Shares Float | 41 (M) |
| Held by Insiders | 1.9 (%) |
| Held by Institutions | 103.5 (%) |
| Shares Short | 2,920 (K) |
| Shares Short P.Month | 3,070 (K) |
| EPS | -0.38 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.38 |
| Profit Margin | -3.3 % |
| Operating Margin | -0.4 % |
| Return on Assets (ttm) | -0.8 % |
| Return on Equity (ttm) | -5.3 % |
| Qtrly Rev. Growth | 31.2 % |
| Gross Profit (p.s.) | 1.33 |
| Sales Per Share | 2.07 |
| EBITDA (p.s.) | -0.04 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 17 (M) |
| Levered Free Cash Flow | 28 (M) |
| PE Ratio | -65.53 |
| PEG Ratio | 0 |
| Price to Book value | 3.37 |
| Price to Sales | 11.97 |
| Price to Cash Flow | 71.19 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|